Participated · Series G · Jun 2026

Helion Energy had been working toward a promised energy breakthrough but fell behind schedule and began running short on cash. The company's financial strain led to a high-profile fundraising effort in which Sam Altman, one of its largest investors, solicited OpenAI to lead a $500 million round at a $35 billion valuation. A significant portion of Altman's personal net worth is reported to be tied to Helion. Within the company, employees who reviewed the proposed financing raised doubts about the viability of the technology. Concern about potential legal exposure led some staff to avoid discussions about the deal in internal Slack channels. The article does not provide revenue, user, or other operating metrics, nor does it detail specific product plans beyond the referenced "energy breakthrough."

Participated · Series D · Dec 2023

GreyOrange builds a full-stack solution for warehouse, fulfillment and 3PL needs that combines autonomous mobile robots (AMRs), forklifts and bin systems for picking with its own first-party (“hardware-agnostic”) fleet management software. The company counts customers including Walmart Canada, Nike and Swedish fast-fashion retailer H&M. Founded in 2011 and headquartered in suburban Roswell, Georgia (roughly 20 miles north of Atlanta), GreyOrange has expanded its product suite since the era following Amazon’s Kiva acquisition. The firm has pursued multiple fundraises to scale its offerings and operations. CEO Akash Gupta said the latest funding will in part go toward delivering systems to customers. GreyOrange develops warehouse and logistics robotics that orchestrate fulfillment and optimize inventory for high-volume shippers. The company sells and deploys robotic systems to fulfillment centers and has notable customer deployments such as a Walmart Canada fulfillment warehouse outfitted with its systems. In 2024 GreyOrange pursued growth financing to fund expansion, hiring and scaled production rather than completing a previously reported IPO push. Much of the new capital will be used to hire roughly 300 roles across engineering, product, marketing and sales, and to ramp production and rollout of its robotic systems. The company was formed in India in 2015 and moved operations to Atlanta, Georgia three years later. Leadership framed the financing as a strategic mix of equity and debt to support continued growth and customer programs. GreyOrange develops robotic systems for warehouses, primarily a robot ‘butler’ that moves heavy shelves and a robotic ‘sorter’ belt that organizes packages. Founded in 2011 and headquartered in Singapore, the company operates five regional offices, three R&D centers and has more than 60 installations with retail customers worldwide. The founders say the vision is to build a holistic solution and to be the first to operate a fully-autonomous warehouse within three to four years. Management aims to deploy over 20,000 robots in the next three years and is targeting major expansion, including a North American headquarters in Atlanta and a planned research center in Boston. The new funding is intended to strengthen the company’s supply chain and scale operations 5–10X over the next couple of years. GreyOrange competes with established players such as Amazon-owned Kiva as it pursues broader warehouse automation. Grey Orange provides automated solutions for the logistics industry, including Butler, an automated storage and goods-to-man order picking system, and Sorter, a high-speed sortation system for order consolidation and routing. Butler is designed to reduce the time it takes to get orders to homes and inventory to stores. The company serves customers such as Flipkart, Jabong, Amazon India, GoJavas, Delhivery, DTDC and Aramex. Co-founded in 2011 by Samay Kohli and Akash Gupta, the company is based in Gurgaon, India. Grey Orange raised $30m in funding and intends to use the proceeds to develop new solutions and expand internationally into Asia, the Middle East and Europe. Grey Orange, founded in 2009 by Samay Kohli and Akash Gupta, develops the Butler System—a fleet of mobile robots for order fulfillment that uses proprietary machine learning and swarm-intelligence algorithms. The company serves large customers in e-commerce, third-party logistics and retail, claiming improved efficiency and reduced operational costs. Grey Orange was built after the founders' earlier work on humanoid robots and focuses on flexible, fast-to-deploy automation versus rigid industrial systems. The firm is headquartered in Gurgaon and Singapore and is preparing to manufacture its next generation of robots. Management says installations will begin in Singapore and other international markets as it scales. The recent Series A was significantly oversubscribed, and the company intends to use proceeds for hiring, R&D, scaling operations and international expansion.

Led · Seed · Oct 2022

Oma Fertility aims to improve in‑vitro fertilization by combining better technology with respectful care and ethical pricing. The company was founded by Gurjeet Singh in 2020. Oma has raised $71.5 million across three funding rounds. Chrissy Meyer and Root Ventures invested in the last two rounds. The company is actively engaging in public outreach—its founder and an investor are scheduled to speak at a TechCrunch Live event. The articles emphasize its mission to make IVF more accessible and patient‑centered. Oma Fertility combines artificial intelligence and robotics with clinical care to reduce the cost and human error associated with IVF. Its initial product, Oma Sperm InSight™, uses AI to identify the most promising sperm cells to improve embryo quality and boost success rates. The company opened its first clinic in Santa Barbara, California in 2021 and announced plans to expand nationally through 2023. Co-founder and CCO Dr. Sahil Gupta previously founded the Aveya clinic chain in India and Nepal and brought demonstrated operational experience to the venture. Oma positions a team of engineers and physicians together to automate manual lab tasks and standardize assessments where embryologists historically disagree. The company markets its approach as making fertility treatments more accessible and affordable compared with typical U.S. IVF pricing.

Led · Series C · Oct 2022

Genetesis develops the CardioFlux biomagnetic imaging platform that leverages magnetocardiography to provide rapid, noninvasive cardiac assessments without radiation, contrast, or exercise. CardioFlux was cleared by the FDA in 2019 and received FDA Breakthrough Device designation in December 2020. The system has been clinically investigated in hundreds of patients with suspected acute and chronic coronary syndromes and in patients with confirmed coronary microvascular dysfunction. Genetesis is completing primary enrollment in the ACCMED trial with participating centers including Cleveland Clinic, Ascension St. John, Wake Forest Baptist Health, and Beaumont Royal Oak Hospital. The company plans to use recent financing to obtain FDA De Novo approval, launch additional clinical trials, and commercialize its biomagnetic systems globally across a variety of care settings. Following the Series C close, total funding exceeds $40 million. Genetesis has developed the CardioFlux Magnetocardiograph (MCG) for chest pain, addressing a problem that causes eight million emergency department visits annually. CardioFlux enables physicians to measure and record the heart's magnetic fields in a few minutes. The system operates without ionizing radiation, without exercise protocols, and without the need for specialized room modifications. The technology has the potential to lower emergency department length of stay for chest pain patients. Financially, the company raised $9.2M in Series B financing that included strategic investments from TDK Ventures and an undisclosed Fortune 500 global healthcare company, alongside return investors CincyTech, Ohio Innovation Fund and Mark Cuban. The company also added Sajid Malhotra to its board. Genetesis develops biomagnetic imaging systems and proprietary software to detect ischemic cardiac tissue and enable rapid, noninvasive chest pain triage. Its CardioFlux system performs a passive 60–90 second scan with no radiation or exercise required. The company completed a 100-patient, double‑blinded clinical study at St. John Hospital and described the findings as encouraging, with plans to publish in peer‑reviewed journals. Genetesis aims to give clinicians an accurate, easy‑to‑operate tool that can reduce the need for invasive and lengthy testing. The company plans to build and install additional CardioFlux systems, launch new clinical trials, and prepare for commercial launch. Genetesis is based in Mason, Ohio and will preview its technology at the American College of Emergency Physicians and American Heart Association Scientific Sessions. Genetesis develops CardioFlux™, a medical device that provides accurate, noninvasive 3D mapping of the heart's electrical activity. The system is intended to diagnose, characterize, and guide treatment for myocardial ischemia, atrial fibrillation, ventricular tachycardia and other arrhythmias, offering more insight than a conventional ECG. The company presented data collected with the Mayo Clinic at the American Heart Association Scientific Sessions showing promising improvements in noninvasive detection of ischemia in high‑risk chest pain compared with existing ER tools. Genetesis was founded in Mason, Ohio in 2013 and now employs a team of ten. The company plans to use the funding to scale engineering, launch additional clinical studies, and seek FDA regulatory clearance. Investors and management also see potential to expand the CardioFlux platform beyond cardiac applications into markets such as magnetic brain imaging.

Participated · Series A · Oct 2022

Juno provides checking accounts tailored for crypto users, enabling customers to take paychecks in digital tokens and spend crypto or cash via a Mastercard-powered debit card. The platform integrates with popular U.S. payroll systems, offers bill payments, and provides zero-fee onramps from checking accounts to Layer 2 networks such as Polygon, Arbitrum, and Optimism. Juno also automates tax reporting through form 1099 for customers, reducing manual transaction and gains calculations. The startup has amassed over 75,000 U.S. customers and reported $1 billion in annualized transaction volume processing. Juno is launching an optional tokenized loyalty program (an ERC-20 called JCOIN) and has generated a 150 million token snapshot for eligible customers. Founders, employees, and investors are not taking token allocations to avoid conflicts of interest. The founding team previously worked on Nuo protocol and positioned the product with compliance at its core to onboard users to web3 via a familiar checking-account interface. Juno is a digital banking platform built on top of Ethereum that relies on the Nuo lending protocol and will offer smart-contract wallets paying 5.5% annual interest on USDC. The flagship product has no fees and includes a Venmo-style peer-to-peer payment option. Juno plans an initial launch in the U.S., Europe, Singapore and Japan and will partner with online money transmitters for on-ramps, with potential future bank partnerships for debit cards and free cross-border payments. The platform says it will fund yields from interest earned on short-term crypto-collateralized loans and margin-trading loans originated through Nuo. Deposits will be insured by a price-volatility insurance fund under development by Nuo as well as smart-contract insurance. Nuo currently reports $25 million in deposits and $20 million in loans disbursed, which the team will leverage as they roll out Juno.